A Phase III Multicenter Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cevimeline in the Treatment of Xerostomia Secondary to Radiation Therapy for Cancer in the Head and Neck Region

Grants and Contracts Details

StatusFinished
Effective start/end date6/1/016/20/02

Funding

  • Daiichi Sankyo Incorporated: $1,250.00